2 completed, 1 recruiting, 1 unknown. 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Not applicable | 1 | Unknown 1 |
Follow Chylous Ascites: new trials by email Literature Review of Chylous Ascites trials Research Report on Chylous Ascites
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral Iohexol in the Management of Chylous Ascites After After Retroperitoneal or Extended Lymphadenectomy oral iohexol, Lymphangiography and Embolization - Chylous Ascites, Abdominal Neoplasm | Phase 2 | Completed | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 42 | 2025-02-15 | 2026-03-06 |
| A Prospective Natural History Study of Lymphatic Anomalies Lymphatic Diseases, Lymphatic Abnormalities | Recruiting | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1200 | 2023-03-20 | 2026-10-23 | |
| Chyle Leak After Pancreatic Surgery Standard care irrespective of CL, Dietary treatment (MCT-diet) - Postoperative Chyle Leak | Not applicable | Unknown | Ludwig-Maximilians - University of Munich | 86 | 2017-05-31 | 2018-08-15 |
| Treatment With Octreotide in Patients With Lymphangioleiomyomatosis Octreotide - Lymphangioleiomyomatosis, Lymphangiomyomas | Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 4 | 2000-06-01 | 2010-04-30 |
Abdominal Neoplasms (1) · Ascites (1) · Chylothorax (1) · Lymphangiectasis (1) · Lymphangioleiomyomatosis (1) · Lymphangiomyoma (1) · Lymphatic Abnormalities (1) · Lymphatic Diseases (1) · Lymphedema (1) · Osteolysis, Essential (1) · Pelvic Neoplasms (1) · Pleural Effusion (1) · Protein-Losing Enteropathies (1)
Digestive System Diseases (4) · Peritoneal Diseases (4) · Hemic and Lymphatic Diseases (2) · Neoplasms (2) · Bone Diseases (1) · Bone Diseases, Developmental (1) · Bone Resorption (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Gastrointestinal Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Intestinal Diseases (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1)
Embolization, Therapeutic (1) · Iohexol (1) · Octreotide (1)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Ludwig-Maximilians - University of Munich (1) · National Heart, Lung, and Blood Institute (NHLBI) (1)
United States (2) · China (1) · Germany (1)
Jan D'Haese, M.D. (1) · Sarah E Sheppard, M.D. (1)